Top

Cardiovascular Diabetology

Published in:

Open Access 01-12-2016 | Original investigation

Low birth weight leads to obesity, diabetes and increased leptin levels in adults: the CoLaus study

Authors: François R. Jornayvaz, Peter Vollenweider, Murielle Bochud, Vincent Mooser, Gérard Waeber, Pedro Marques-Vidal

Published in: Cardiovascular Diabetology | Issue 1/2016

Abstract

Background

Low birth weight is associated with increased rates of obesity, insulin resistance and type 2 diabetes, but the precise mechanisms for this association remain unclear. We aimed to assess the relationships between birth weight and markers of glucose homeostasis or obesity in adults.

Methods

Cross-sectional population-based study on 1458 women and 1088 men aged 35–75 years living in Lausanne, Switzerland. Birth weight was self-reported and categorized into ≤2.5, 2.6–3.5, 3.6–4.0 and >4.0 kg. Body composition was assessed by bioimpedance. Leptin and adiponectin levels were measured by ELISA.

Results

Women with low birth weight (≤2.5 kg) had higher levels of fasting plasma glucose, insulin, HOMA, diabetes and metabolic syndrome; a non significant similar trend was seen in men. In both genders, height increased with birth weight, whereas a U-shaped association was found between birth weight and body mass index, waist circumference and body fat percentage. After adjusting for age, smoking status, physical activity and fat mass, an inverse association was found between leptin and birth weight categories: adjusted mean ± standard error 17.3 ± 0.7, 16.2 ± 0.3, 15.6 ± 0.5 and 14.0 ± 0.8 ng/dL for birth weight categories ≤2.5, 2.6–3.5, 3.6–4.0 and >4.0 kg, respectively, in women (p < 0.05) and 9.8 ± 0.8, 9.1 ± 03, 7.8 ± 0.4 and 7.7 ± 0.5 ng/dL in men (p < 0.05). An inverse association was also found between reported birth weight and leptin to fat mass ratio: mean ± standard error 0.77 ± 0.04, 0.73 ± 0.02, 0.69 ± 0.03 and 0.62 ± 0.04 in women (p < 0.05); 0.46 ± 0.05, 0.45 ± 0.02, 0.39 ± 0.02 and 0.38 ± 0.03 in men (p < 0.05). No differences in adiponectin levels were found between birth weight groups.

Conclusions

Middle-aged adults born with a low weight present a higher prevalence of diabetes and obesity and also higher leptin levels and leptin to fat mass ratio than adults born with a normal weight. The higher leptin levels and leptin to fat mass ratio among adults born with a low weight might be related to nutritional factors during childhood or to the development of leptin resistance and/or higher leptin production by body fat unit. Subjects born with a low weight should be counselled regarding the risks of developing diabetes and/or cardiovascular disease.

Available only for authorised users

Barker DJ. The developmental origins of chronic adult disease. Acta Paediatr Suppl. 2004;93(446):26–33.PubMed

Alberti KG, Zimmet P, Shaw J. Metabolic syndrome—a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med. 2006;23(5):469–80.CrossRefPubMed

Jornayvaz FR, Selz R, Tappy L, Theintz GE. Metabolism of oral glucose in children born small for gestational age: evidence for an impaired whole body glucose oxidation. Metabolism. 2004;53(7):847–51.CrossRefPubMed

Lissner L, Karlsson C, Lindroos AK, Sjöström L, Carlsson B, Carlsson L, Bengtsson C. Birth weight, adulthood BMI, and subsequent weight gain in relation to leptin levels in Swedish women. Obes Res. 1999;7(2):150–4.CrossRefPubMed

Phillips DI, Fall CH, Cooper C, Norman RJ, Robinson JS, Owens PC. Size at birth and plasma leptin concentrations in adult life. Int J Obes Relat Metab Disord. 1999;23(10):1025–9.CrossRefPubMed

Miras M, Ochetti M, Martin S, Silvano L, Sobrero G, Castro L, Onassis M, Tolosa de Talamoni N, Perez A, Picotto G, et al. Serum levels of adiponectin and leptin in children born small for gestational age: relation to insulin sensitivity parameters. J Pediatr Endocrinol Metab. 2010;23(5):463–71.PubMed

Kotani Y, Yokota I, Kitamura S, Matsuda J, Naito E, Kuroda Y. Plasma adiponectin levels in newborns are higher than those in adults and positively correlated with birth weight. Clin Endocrinol. 2004;61(4):418–23.CrossRef

Ley SH, Harris SB, Connelly PW, Mamakeesick M, Gittelsohn J, Hegele RA, Retnakaran R, Zinman B, Hanley AJ. Adipokines and incident type 2 diabetes in an aboriginal Canadian [corrected] population: the Sandy lake health and diabetes project. Diabetes Care. 2008;31(7):1410–5.CrossRefPubMedPubMedCentral

Lindsay RS, Walker JD, Havel PJ, Hamilton BA, Calder AA, Johnstone FD. Adiponectin is present in cord blood but is unrelated to birth weight. Diabetes Care. 2003;26(8):2244–9.CrossRefPubMed

10.

Firmann M, Mayor V, Marques Vidal P, Bochud M, Pécoud A, Hayoz D, Paccaud F, Preisig M, Song KS, Yuan X, et al. The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc Disord. 2008;8(1):6.CrossRefPubMedPubMedCentral

11.

World Health Oranisation. Obesity: preventing and managing the global epidemic: report of a WHO consultation. vol. 894. In: World Health Oranisation editor. Geneva: World Health Organization; 1999. p. 1–268.

12.

Ramel A, Geirsdottir OG, Arnarson A, Thorsdottir I. Regional and total body bioelectrical impedance analysis compared with DXA in Icelandic elderly. Eur J Clin Nutr. 2011;65(8):978–83.CrossRefPubMed

13.

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9.CrossRefPubMed

14.

Bennett FI, Farlane-Anderson N, Wilks R, Luke A, Cooper RS, Forrester TE. Leptin concentration in women is influenced by regional distribution of adipose tissue. Am J Clin Nutr. 1997;66(6):1340–4.PubMed

15.

Singhal A, Farooqi IS, O’Rahilly S, Cole TJ, Fewtrell M, Lucas A. Early nutrition and leptin concentrations in later life. Am J Clin Nutr. 2002;75(6):993–9.PubMed

16.

Oken E, Gillman MW. Fetal origins of obesity. Obes Res. 2003;11(4):496–506.CrossRefPubMed

17.

Tam CH, Wang Y, Luan J, Lee HM, Luk AO, Tutino GE, Tong PC, Ko GT, Ozaki R, Tam WH, et al. Non-linear relationship between birthweight and cardiometabolic risk factors in Chinese adolescents and adults. Diabetic medicine: a journal of the British Diabetic Association. 2015;32(2):220–5.CrossRef

18.

Bandaru P, Shankar A. Association between plasma leptin levels and diabetes mellitus. Metab Syndr Relat Disord. 2011;9(1):19–23.CrossRefPubMedPubMedCentral

19.

Flier JS. Clinical review 94: What’s in a name? In search of leptin’s physiologic role. J Clin Endocrinol Metab. 1998;83(5):1407–13.PubMed

20.

Jaquet D, Gaboriau A, Czernichow P, Levy-Marchal C. Relatively low serum leptin levels in adults born with intra-uterine growth retardation. Int J Obes Relat Metab Disord. 2001;25(4):491–5.CrossRefPubMed

21.

Melo AS, Bettiol H, Silva AA, Rosa-e-Silva AC, Cardoso VC, Reis RM, Ferriani RA, Barbieri MA, Vieira CS. Small for gestational age babies are not related to changes in markers of adipose tissue dysfunction during reproductive age. Early Hum Dev. 2014;90(5):231–5.CrossRefPubMed

22.

Jaquet D, Leger J, Tabone MD, Czernichow P, Lévy-Marchal C. High serum leptin concentrations during catch-up growth of children born with intrauterine growth retardation. J Clin Endocrinol Metab. 1999;84(6):1949–53.PubMed

23.

Bieswal F, Ahn MT, Reusens B, Holvoet P, Raes M, Rees WD, Remacle C. The importance of catch-up growth after early malnutrition for the programming of obesity in male rat. Obesity. 2006;14(8):1330–43.CrossRefPubMed

24.

Guan H, Arany E, van Beek JP, Chamson-Reig A, Thyssen S, Hill DJ, Yang K. Adipose tissue gene expression profiling reveals distinct molecular pathways that define visceral adiposity in offspring of maternal protein-restricted rats. Am J Physiol Endocrinol Metab. 2005;288(4):E663–73.CrossRefPubMed

25.

Couillard C, Mauriège P, Imbeault P, Prud’homme D, Nadeau A, Tremblay A, Bouchard C, Després JP. Hyperleptinemia is more closely associated with adipose cell hypertrophy than with adipose tissue hyperplasia. Int J Obes Relat Metab Disord. 2000;24(6):782–8.CrossRefPubMed

26.

Schultz NS, Broholm C, Gillberg L, Mortensen B, Jorgensen SW, Schultz HS, Scheele C, Wojtaszewski JF, Pedersen BK, Vaag A. Impaired leptin gene expression and release in cultured preadipocytes isolated from individuals born with low birth weight. Diabetes. 2014;63(1):111–21.CrossRefPubMed

27.

Young GA, Woodrow G, Kendall S, Oldroyd B, Turney JH, Brownjohn AM, Smith MA. Increased plasma leptin/fat ratio in patients with chronic renal failure: a cause of malnutrition? Nephrol Dial Transplant. 1997;12(11):2318–23.CrossRefPubMed

28.

Baidal JAW, Locks LM, Cheng ER, Blake-Lamb TL, Perkins ME, Taveras EM. Risk factors for childhood obesity in the first 1000 days: a systematic review. Am J Prev Med. 2016. doi:10.1016/j.amepre.2015.11.012.

29.

Palatianou ME, Simos YV, Andronikou SK, Kiortsis DN. Long-term metabolic effects of high birth weight: a critical review of the literature. Horm Metab Res. 2014;46(13):911–20.CrossRefPubMed

30.

Wells JC, Chomtho S, Fewtrell MS. Programming of body composition by early growth and nutrition. Proc Nutr Soc. 2007;66(3):423–34.CrossRefPubMed

31.

Ferreira RJ, Marques-Vidal PM. Prevalence and determinants of obesity in children in public schools of Sintra, Portugal. Obesity. 2008;16(2):497–500.CrossRefPubMed

32.

Reilly JJ, Armstrong J, Dorosty AR, Emmett PM, Ness A, Rogers I, Steer C, Sherriff A. Early life risk factors for obesity in childhood: cohort study. BMJ. 2005;330(7504):1357.CrossRefPubMedPubMedCentral

33.

Ruiz-Narváez EA, Palmer JR, Gerlovin H, Wise LA, Vimalananda VG, Rosenzweig JL, Rosenberg L. Birth weight and risk of type 2 diabetes in the black women’s health study: does adult BMI play a mediating role? Diabetes Care. 2014;37(9):2572–8.CrossRefPubMedPubMedCentral

34.

Cameron AJ, Spence AC, Laws R, Hesketh KD, Lioret S, Campbell KJ. A review of the relationship between socioeconomic position and the early-life predictors of obesity. Curr Obes Rep. 2015;4(3):350–62.CrossRefPubMed

35.

Bellone S, Rapa A, Petri A, Zavallone A, Strigini L, Chiorboli E, Ciardi L, Aguzzi A, Bona G. Leptin levels as function of age, gender, auxological and hormonal parameters in 202 healthy neonates at birth and during the first month of life. J Endocrinol Invest. 2004;27(1):18–23.CrossRefPubMed

36.

Chiesa C, Osborn JF, Haass C, Natale F, Spinelli M, Scapillati E, Spinelli A, Pacifico L. Ghrelin, leptin, IGF-1, IGFBP-3, and insulin concentrations at birth: is there a relationship with fetal growth and neonatal anthropometry? Clin Chem. 2008;54(3):550–8.CrossRefPubMed

37.

Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001;86(5):1930–5.CrossRefPubMed

38.

Jaquet D, Deghmoun S, Chevenne D, Czernichow P, Lévy-Marchal C. Low serum adiponectin levels in subjects born small for gestational age: impact on insulin sensitivity. Int J Obes. 2006;30(1):83–7.CrossRef

39.

Challa AS, Evagelidou EN, Cholevas VI, Kiortsis DN, Giapros VI, Drougia AA, Andronikou SK. Growth factors and adipocytokines in prepubertal children born small for gestational age: relation to insulin resistance. Diabetes Care. 2009;32(4):714–9.CrossRefPubMedPubMedCentral

40.

Boyne MS, Thompson DS, Osmond C, Fraser RA, Thame MM, Taylor-Bryan C, Soares-Wynter S, Forrester TE. The effect of antenatal factors and postnatal growth on serum adiponectin levels in children. J Dev Orig Health Dis. 2013;4(4):317–23.CrossRefPubMed

41.

Tamakoshi K, Yatsuya H, Wada K, Matsushita K, Otsuka R, Sugiura K, Kondo T, Toyoshima H. Low birth weight is associated with reduced adiponectin concentration in adult. Ann Epidemiol. 2006;16(9):669–74.CrossRefPubMed

42.

Law CM, Barker DJ, Osmond C, Fall CH, Simmonds SJ. Early growth and abdominal fatness in adult life. J Epidemiol Community Health. 1992;46(3):184–6.CrossRefPubMedPubMedCentral

43.

Eriksson JG, Kajantie E, Lampl M, Osmond C. Trajectories of body mass index amongst children who develop type 2 diabetes as adults. J Intern Med. 2015;278(2):219–26.CrossRefPubMed

44.

Araujo de Franca GV, Lucia Rolfe ED, Horta BL, Gigante DP, Yudkin JS, Ong KK, Victora CG. Associations of birth weight, linear growth and relative weight gain throughout life with abdominal fat depots in adulthood: the 1982 Pelotas (Brazil) birth cohort study. Int J Obes. 2016;40(1):14–21.CrossRef

45.

Araujo de Franca GV, Restrepo-Mendez MC, Loret de Mola C, Victora CG. Size at birth and abdominal adiposity in adults: a systematic review and meta-analysis. Obes Rev. 2014;15(2):77–91.CrossRefPubMed

46.

Demerath EW, Reed D, Choh AC, Soloway L, Lee M, Czerwinski SA, Chumlea WC, Siervogel RM, Towne B. Rapid postnatal weight gain and visceral adiposity in adulthood: the Fels Longitudinal Study. Obesity. 2009;17(11):2060–6.CrossRefPubMedPubMedCentral

47.

Rolfe Ede L, Loos RJ, Druet C, Stolk RP, Ekelund U, Griffin SJ, Forouhi NG, Wareham NJ, Ong KK. Association between birth weight and visceral fat in adults. Am J Clin Nutr. 2010;92(2):347–52.CrossRefPubMed

48.

Kajantie E, Osmond C, Barker DJ, Forsén T, Phillips DI, Eriksson JG. Size at birth as a predictor of mortality in adulthood: a follow-up of 35,0000 person-years. Int J Epidemiol. 2005;34(3):655–63.CrossRefPubMed

49.

Kurajoh M, Koyama H, Kadoya M, Naka M, Miyoshi A, Kanzaki A, Kakutani-Hatayama M, Okazaki H, Shoji T, Moriwaki Y, et al. Plasma leptin level is associated with cardiac autonomic dysfunction in patients with type 2 diabetes: HSCAA study. Cardiovasc Diabetol. 2015;14:117.CrossRefPubMedPubMedCentral

50.

Vavruch C, Länne T, Fredrikson M, Lindström T, Östgren CJ, Nyström FH. Serum leptin levels are independently related to the incidence of ischemic heart disease in a prospective study of patients with type 2 diabetes. Cardiovasc Diabetol. 2015;14:62.CrossRefPubMedPubMedCentral

51.

Visentin S, Grumolato F, Nardelli GB, Di Camillo B, Grisan E, Cosmi E. Early origins of adult disease: low birth weight and vascular remodeling. Atherosclerosis. 2014;237(2):391–9.CrossRefPubMed

52.

Johnsson IW, Haglund B, Ahlsson F, Gustafsson J. A high birth weight is associated with increased risk of type 2 diabetes and obesity. Pediatr Obes. 2015;10(2):77–83.CrossRefPubMed

53.

Andersson EA, Pilgaard K, Pisinger C, Harder MN, Grarup N, Faerch K, Poulsen P, Witte DR, Jorgensen T, Vaag A, et al. Type 2 diabetes risk alleles near ADCY5, CDKAL1 and HHEX-IDE are associated with reduced birthweight. Diabetologia. 2010;53(9):1908–16.CrossRefPubMed

54.

Freathy RM, Bennett AJ, Ring SM, Shields B, Groves CJ, Timpson NJ, Weedon MN, Zeggini E, Lindgren CM, Lango H, et al. Type 2 diabetes risk alleles are associated with reduced size at birth. Diabetes. 2009;58(6):1428–33.CrossRefPubMedPubMedCentral

55.

Mueller NT, Duncan BB, Barreto SM, Chor D, Bessel M, Aquino EM, Pereira MA, Schmidt MI. Earlier age at menarche is associated with higher diabetes risk and cardiometabolic disease risk factors in Brazilian adults: Brazilian longitudinal study of adult health (ELSA-Brasil). Cardiovasc Diabetol. 2014;13:22.CrossRefPubMedPubMedCentral

56.

Galea S, Tracy M. Participation rates in epidemiologic studies. Ann Epidemiol. 2007;17(9):643–53.CrossRefPubMed

57.

Troy LM, Michels KB, Hunter DJ, Spiegelman D, Manson JE, Colditz GA, Stampfer MJ, Willett WC. Self-reported birthweight and history of having been breastfed among younger women: an assessment of validity. Int J Epidemiol. 1996;25(1):122–7.CrossRefPubMed

Title: Low birth weight leads to obesity, diabetes and increased leptin levels in adults: the CoLaus study
Authors: François R. Jornayvaz
Peter Vollenweider
Murielle Bochud
Vincent Mooser
Gérard Waeber
Pedro Marques-Vidal
Publication date: 01-12-2016
Publisher: BioMed Central
Published in: Cardiovascular Diabetology / Issue 1/2016
Electronic ISSN: 1475-2840
DOI: https://doi.org/10.1186/s12933-016-0389-2

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2016

Circulating angiopoietin-like protein 8 (betatrophin) association with HsCRP and metabolic syndrome

Erratum to: Apolipoprotein E gene polymorphism and risk of type 2 diabetes and cardiovascular disease

Changes in triglycerides and high-density lipoprotein cholesterol may precede peripheral insulin resistance, with 2-h insulin partially mediating this unidirectional relationship: a prospective cohort study

Emerging role of chemokine CC motif ligand 4 related mechanisms in diabetes mellitus and cardiovascular disease: friends or foes?

The effect of perioperative insulin treatment on cardiodepression in mild adiposity in mice

Impact of teneligliptin on oxidative stress and endothelial function in type 2 diabetes patients with chronic kidney disease: a case–control study

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials